Anthropic's New Claude Opus 4.7 Model Is Not Mythos Preview
Digest more
Researchers say a new AI system can identify disease-causing mutations and explain their biological effects, potentially changing how genetic disorders are diagnosed.
Paris-based Mistral wanted to develop a top-tier AI model to rival OpenAI and Anthropic. That didn’t work out. But it turns out lots of folks don’t care if the AI is bleeding edge – as long as it wasn’t made in America or China.
Bank executives are taking Anthropic's new AI seriously, but cybersecurity experts are dismissing the doomsday framing as a clever marketing schtick.
Experts say Mythos potentially has an unprecedented ability to identify and exploit cybersecurity weaknesses.
That human-accountable model makes the most sense to me. By all means, integrate AI into the systems employees already use and let it take over the repetitive, time-consuming drudgery of the job. But we still need someone to vet the results and decide whether it makes sense.
If you've been using Anthropic's Claude AI, you're probably wondering when the next big upgrade is coming. The company has been on an aggressive
Anthropic was discussing Mythos with the Trump administration, even after the Pentagon cut off business with the U.S. AI lab following a contract dispute.
Pianpian Xu Guthrie, Amotions AI’s founder, was eager to tell me more. The AI model observes video calls on your computer, she said, and gives you real-time tips based on the other person’s tone and facial expression.